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Thirteen soldiers (11 men and two women) were exposed to zinc chloride smoke (ZCS) during a combat exercise. 
Even though their initial symptoms were modest, a prolonged follow up with lung function testing and blood 
samples was undertaken due to previous cases with fatal outcome after exposure to ZCS. Four weeks after exposure 
there were statistically significant declines from baseline values in lung diffusion capacity and total lung capacity of 
16.2% and 4.3%, respectively. At the same time plasma levels of fibrinogen and zinc were significantly elevated, 
though mainly within the normal range. All variables showed a tendency towards normalization at follow up 8 
weeks and 6 months after exposure. These findings indicate an unexpected quantifiable damage to lung parenchyma 
with a remarkable delay after modest exposure to zinc chloride smoke despite sparse initial symptoms. 
Exposure to high concentrations of ZCS may induce adult respiratory distress syndrome (ARDS) after a 
symptom free period of up to 12 days from exposure. Even though none of the soldiers in the present study 
developed ARDS the assessment of lung diffusion capacity and acute phase reactants is proposed as a supplement 
when monitoring patients after exposure to ZCS. 
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Introduction 
Zinc chloride smoke (ZCS) screens are used for both 
military and civilian screening purposes. The use of these 
smoke bombs in confined spaces has been widely aban- 
doned due to several lethal incidents (l-3). However, the 
use of ZCS in open air is considered safe within certain 
limitations (4,5). 
Immediate symptoms after exposure may be irritation 
of the eyes and the upper respiratory tract with lachryma- 
tion, metallic taste, coughing, hoarseness and soreness of 
the throat, which in mild cases last from a few hours to a 
few weeks (6,7). In more severe cases nausea vomiting, 
chest pain, and headache also occur (8,9). Clinical and 
paraclinical findings include cyanosis, pyrexia, leucocyto- 
sis (mostly polymorfonuclear leucocytes), reduced vital 
capacity (VC) and forced expiratory volume in 1 set 
(FEV1) at the peak of symptoms with recovery during 
convalescence, increased zinc urinary excretion and 
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various degrees of hypoxemia. Chest radiographs may 
show diffuse infiltration that in some cases persist in 
various degrees without clinical symptoms. In more severe 
cases emphysematous bullae and pneumothorax occur 
(10). 
Exposure to high concentrations may induce adult 
respiratory distress syndrome (ARDS) after a symptom 
free period of up to 12 days from exposure (11,12). The 
outcome is frequently fatal, and in such cases autopsies 
have shown extensive interstitial and intra-alveolar space 
fibrosis and arterial and venous lumen reduction as well as 
obliteration and widespread occlusion of microvessels. 
However, the exact mechanism by which ARDS is triggered 
is unknown (13). In exceedingly high concentrations of ZCS 
death is caused within hours by oedema of the larynx and 
spasm of the glottis (14). In lesser but still very high 
concentrations severe haemorrhagic ulceration and excor- 
iation of the upper respiratory tract may lead to a fatal 
outcome (1). 
At present, only casuistic reports have dealt with 
diffusion capacity after ZCS exposure (11,15,16). We 
describe a 6-month follow up of lung function variables 
and specific serum variables in 13 soldiers, who were 
exposed to modest concentrations of ZCS during a routine 
military exercise. 
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Material and methods 
PATIENTS 
Thirteen soldiers, (two women and 11 men) aged 19 to 26 
(median age 20 years) were exposed to ZCS during a 
combat exercise. Eleven of the soldiers were never smokers 
while the remaining two were present smokers (4.25 and 6 
pack-years, respectively). The soldiers were together with 
nine unexposed colleagues either defending or attacking a 
combat exercise building with a wide door and window 
openings. A total of two smoke canisters were ignited in the 
open air, but due to wind conditions the smoke drifted into 
the combat exercise building through the open windows 
and doors. Two of the soldiers inside the building were 
exposed for 5-10 min without airway protection. The 
remaining 11 soldiers were briefly exposed while running 
through the plume of smoke and/or upon entering the 
combat exercise building. 
Primarily 12 of the soldiers were hospitalized on the day 
of exposure for observation due to soreness of the throat, 
coughing, chest pain and mild headache. None of the 
soldiers had severe respiratory symptoms when admitted, 
but four of them complained of dyspnoea during the 
combat exercise. 
Upon admittance all soldiers were treated with inhalation 
of 1 mg budesonide and 200 mg intravenous hydrocortisone 
followed by 75 mg oral prednisolone after 12 h. Four 
soldiers were then treated with oral prednisolone 40 mg 
daily for 1 week and then gradual reduction in dose with 
Smg every third day. Three of the soldiers were treated 
because of the duration and concentration of smoke 
exposition and the fourth was treated because of persistent 
coughing and chest pain. This soldier had a laryngoscopy 
5 days after exposure, showing signs of hypopharyngeal 
inflammation interpreted as chemical pharyngitis. 
One soldier was treated for 18 h with intravenous 
N-acetylcysteine (140 mg kg-’ day-‘) until blood samples 
were obtained showing normal values for plasma zinc. 
The thirteenth soldier was admitted to hospital the day 
after exposure due to mild initial symptoms. He was not 
treated with steroids but joined the follow-up programme. 
haemoglobin content (DLCO,,,) and diffusing capacity per 
alveolar volume (DL/Va) were recorded (18). TLC and 
DLCOcorr were determined with the single breath technique 
after inhalation of a gas mixture containing carbon 
monoxide and neon with the latter as an indicator of the 
dilution. The better of two results that differed no more 
than 3% was used as the final test result. Only experienced 
lung function technicians performed the tests. Lung 
diffusion capacity was adjusted for haemoglobin level 
according to Cotes et al. (19). 
Blood samples were obtained from all soldiers on the 
second day and subsequently after 1, 2,4, and 8 weeks. At 
day 0 blood samples were obtained from 10 of the soldiers 
and 29 weeks after exposure from 11 of the soldiers. From 
these blood samples plasma levels of zinc, fibrinogen and C- 
reactive protein were determined along with haemoglobin, 
blood sedimentation rate and differentiated while blood cell 
counts. Also serum levels of YKL40 (human cartilage 
glycoprotein-39) and the aminoterminal propeptides of 
type 1 and type III collagen (PINP and PIIINP) were 
determined on each blood sample. YKL40 is an 18- 
glycosyl hydrolase that has been suggested to function in 
the degradation of extracellular matrix or tissue inflamma- 
tion (20,21). Both PINP and PIIINP are regarded as 
markers of formation of collagen type I and III respectively 
(22,23). However, blood samples were only sufficient for 
determination of YKL40, PIIINP and PINP at day 0 and 
day 1 for 10 of the soldiers and from day 2 for 12 of the 
soldiers. Serum levels of YKL-40 and PIIINP were 
determined by radio immunoassays (20,23) and PINP by 
enzyme linked immunosorbent assay (22). 
Radiographs of the thorax and arterial blood gas 
analyses were also obtained from day 1 after exposure 
and during follow-up. 
DATA ANALYSIS 
Changes in lung function variables and blood analyses with 
time were tested using the Wilcoxon non-parametric test for 
paired data and the Friedmann non-parametric test for 
several related samples. 
Results 
METHODS 
All soldiers had spirometry and lung diffusion capacity 
testing performed using a Pulmonary Function Testing 
System 1070 (Medical Graphics Corp. Minnesota, U.S.A.). 
One soldier however, had her first lung function test 
performed at another hospital in Copenhagen county. The 
results from the latter test have been used as her baseline 
values and have not been presented in the preliminary study 
on our results (17). All soldiers had the first lung function 
test upon the first day after exposure. 
The following pulmonary variables were recorded at each 
session: Vital capacity (VC), forced expiratory volume in 
1 set (FEVt), maximal expiratory flow when xx% of the 
FVC remains to be delivered (MEF,), total lung capacity 
(TLC), lung diffusion capacity with adjustment for actual 
Data regarding changes in lung function variables for the 
13 exposed soldiers are listed in Table 1. All baseline values 
for lung function were within normal range when compared 
to a Danish reference population (24). Significant declines 
in DLCO,,,, TLC, and Dl/Va.were found, with the lowest 
values observed 4 weeks after exposure. MEFzs was also 
lower 4 weeks after exposure compared to baseline values, 
but the Friedmann test only showed a trend towards 
significance. The development of changes in DLCO,,, 
compared to initial values is illustrated in Fig. 1. A 
significant increase in VC was found 2 weeks after 
exposure. During follow-up we observed no significant 
drifts or jumps with time during routine calibration tests of 
the pulmonary test system. We were not able to demon- 
strate any correlation between the degree of exposure, 
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Weeks after mild exposure 
to zinc chloride smoke 
FIG 1. Changes from values at day of DLCO,,,, in percent 
and of plasma zinc and fibrinogen in ,u mol-’ after 
modest exposure to zinc chloride smoke. *P<O.O5; 
**p<o.o2; ***p<o.o1. 
treatment with steroids, or smoking and the changes in lung 
function variables. 
None of the soldiers had leucocytosis upon admittance. 
But the initial levels of both neutrophils and monocytes 
were significantly higher than 29 weeks after exposure (36% 
and 25% respectively, P-c 0.01). Only the four soldiers who 
received oral prednisolone had levels of neutrophils above 
normal range during follow-up. 
Plasma levels of fibrinogen were significantly elevated 
during a period from 1-8 weeks after exposure compared to 
initial values and some peak values exceeded normal range 
(Fig. 1). Plasma levels of zinc were above initial values at 2- 
8 weeks after exposure (Fig. 1). Individual peak levels for 
plasma zinc were dispersed over a wide range of time from 
the second day to 8 weeks after exposure and remained 
within normal range. Five out of the 13 soldiers had slightly 
elevated plasma levels of CRP and eight out of 13 had a 
slight increase in blood sedimentation rate during the 
period from 2-8 weeks after exposure. We were not able to 
demonstrate a correlation between changes in lung function 
variables and changes in plasma levels of zinc or fibrinogen. 
Plasma level of YKL-40 increased by median 1118% 
from day zero to day two (n = 10, P= 0.005). No differences 
from baseline values were found during the remaining 
follow-up period. For all soldiers both plasma levels of 
PIIINP and PINP declined from day 0 to day 1 by median 
32%, PcO.01, n= 10. No significant changes with time for 
either of the two collagen formation markers were found 
hereafter. 
Chest radiographs and arterial blood gas analyses 
remained normal for all the soldiers during follow-up. 
Discussion 
We have demonstrated a significant decrease in DLCO,,,,, 
TLC and Dl/Va after modest open-air exposure to ZCS 
with a corresponding increase in serum levels of fibrinogen 
and zinc. These findings indicate that sufficient amounts of 
ZCS must have passed deeply enough into the lower 
respiratory tract to induce a quantifiable reduction in lung 
function. 
Preliminary data and statistics on changes in DLCO,,,, 
after exposure to ZCS from the present study have already 
been published (17). The present study is an expanded 
version with prolonged follow-up, improved computed 
statistical analyses and extended blood sample analyses. 
Gas transfer for carbon monoxide after exposure to ZCS 
has only been described previously in three singular cases. 
One was found normal (1 l), another had a slight reduction 
in DLCO 4 months after exposure (15) and the third one 
showed moderate to severe reduction 2 weeks after 
exposition with recovery after 2-3 months (16). A ZCS 
bomb contains hexachlorethane (C&), zinc oxide (ZnO) 
and calcium silicide (CaS$ along with minor amounts of 
aluminium, magnesium and ammonium chloride. When 
ignited these components form mainly zinc chloride 
(ZnClz), which again in aqueous solution forms hydro- 
chloric acid (HCl) and zinc oxychloride (ZnClOH) (4). 
These three chemicals are all corrosive. Also minor 
amounts of phosgene (COCQ carbon monoxide (CO) 
and polyaromatic hydrocarbons are produced, but the 
pulmonary and toxic impact of these compounds is 
generally considered to be of little or no importance in this 
context (25). 
In confined spaces an ignited smoke bomb rapidly 
absorbs all available moisture from the air. In such a case 
the main component of the smoke will be zinc chloride in 
minute sized particles ranging from 0.01 to 25~ (7) which 
may pass deep into the respiratory tract (26). With 
increasing air humidity successively larger amounts of zinc 
chloride will be hydrolysed into hydrochloric acid and zinc 
oxychloride. The hydrochloric acid absorbs comparably 
more water and forms larger particles mainly deposited in 
the upper respiratory tract (27). 
In rats ZCS induces pulmonary oedema, alveolitis and 
subsequently fibrosis (28). The pathological findings after 
fatal cases in man are similar. They include extensive 
interstitial and intra-alveolar fibrosis, diffuse microvascular 
obliteration and widespread occlusion of the pulmonary 
arteries (29). The progression of ARDS is suggested to be 
mediated through a programmed release of mediators from 
recruited and activated inflammatory cells and stimulation 
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of mediator cascades that include cytokine interactions 
(13). 
The increase in serum levels of fibrinogen and zinc and 
the decline in ,DLCO,,,, TLC, Dl/Va and to a lesser extent 
MEFz5 is compatible with an ulcerative and fibrotic process 
in the lung alveoli and smaller bronchioli with a delayed 
onset and an apparent maximum at 4 weeks after exposure 
(30). However, the modest symptoms of the soldiers did not 
justify attempts to verify this by histology neither by biopsy 
nor by bronchoalveolar lavage. The following healing 
response seems slow, and one cannot rule out the possibility 
of permanent damage from the present data. The slight 
increase in VC and FVC found 2 weeks after exposure can 
be explained by adaptation to the test procedure. It is also 
noteworthy that the reduction VC and FEVr described in 
patients with heavy exposure to ZCS was not demonstrable 
in the present material. This may indicate that DLCO,,,,, 
TLC and Dl/Va are more sensitive procedures in such cases 
with mild exposure. Although a sufficiently matched 
control group was not obtainable due to the acute 
circumstances of the study, we are confident that the 
observed changes are not due to circadian variations or 
lung function technicians. 
YKL40 is presumed to function in tissue remodelling 
and serum YKL40 levels are elevated in patients with 
active rheumatoid arthritis (20) in patients with liver 
fibrosis (21) and in patients with recurrent breast cancer 
and metastases to bone and viscera (31). YKL-40 is secreted 
by human macrophages (32) and is a matrix protein in 
specific granules of human neutrophils. The early and 
significant rise in serum levels of YKL40 may signal early 
tissue damage. The increase in YKL-40 may have been 
larger if the patients had not been treated with predniso- 
lone, since glucocorticoid administration to patients with 
non-infectious inflammatory diseases leads to reductions in 
serum YKL40 within 1 day (Julia S. Johansen, personal 
communication). The decline found from day 0 to day 1 for 
PIIINP and PINP is most probably due to the glucocorti- 
coid treatment. The lack of significant changes in PIIINP 
and PINP does not rule out their importance in this context 
as at least PIIINP already has been shown to be elevated in 
ARDS (33,34). The lower numbers of blood samples for 
analysis of these markers may have hidden important 
information on the degree of fibrosis or simply reflect the 
low degree of exposure. 
Since peak levels of serum zinc appear late in the follow- 
up period and are merging peak levels of fibrinogen, zinc 
level in serum seem to act as an acute phase reactant rather 
than expressing the initial degree of exposure. 
Prolonged observation after exposure is in general 
recommended in the presence of diffuse infiltration on 
chest radiograph, pyrexia, leucocytosis and elevated levels 
of zinc in urine or blood. Such findings may indicate 
exposure of zinc chloride or zinc oxychloride to the alveoli. 
Recently, the immediate damage to lung parenchyma has 
also been determined by technetium-99m DTPA radio- 
aerosol inhalation lung scintigraphy (35). Since none of the 
exposed soldiers from this study developed ARDS one may 
only speculate that the development of acute phase 
reactants and DLCO,,,, after ZCS exposure may 
contribute to early diagnosis of ARDS. But it is important 
to point out that even modest exposure to ZCS leads to 
quantifiable changes in both lung function and acute phase 
reactants. This finding justifies the inclusion of phase 
reactants and determination of DLCO,,,, when monitoring 
patients after exposure to ZCS. 
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